ACCU-BREAK Pharmaceuticals, Inc. Issued First Two Patents for Its Accu-Break(TM) Technologies  
2/14/2008 9:41:54 AM

PLANTATION, Fla.--(BUSINESS WIRE)--Accu-Break Pharmaceuticals, Inc. (“ABP”), a company with a suite of pharmaceutical tablet technologies for creating divisible dosage forms, announced today the recent issuance of two patents covering its Accu-Break technologies. Tablets made in the Accu-Break format contain a drug-free layer that may be used as a break zone should the dose need to be adjusted. The technologies are intended to create pharmaceutical tablets that can be easily divided into precise doses to facilitate titration, dose adjustment and individualized dosing.